Question 1

What are the potential benefits of participating in this trial compared to standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma clinical trial (NCT04039607). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the side effects of nivolumab and ipilimumab compare to those of sorafenib or lenvatinib?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma clinical trial (NCT04039607). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma clinical trial (NCT04039607). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific tests or procedures I will need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma clinical trial (NCT04039607). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma clinical trial (NCT04039607). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or if my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma clinical trial (NCT04039607). Contact the study team or your healthcare provider for specific answers.

What this study is about